Resources from the same session
KEYNOTE-181: Pembrolizumab vs chemotherapy in patients (pts) with advanced/metastatic adenocarcinoma (AC) or squamous cell carcinoma (SCC) of the esophagus as second-line (2L) therapy
Presenter: Sung-Bae Kim
Session: Mini Oral session - Gastrointestinal tumours
Resources:
Slides
Webcast
Pembrolizumab + chemotherapy for advanced G/GEJ adenocarcinoma (GC): The phase III KEYNOTE-062 study
Presenter: Hyun Cheol Chung
Session: Mini Oral session - Gastrointestinal tumours
Resources:
Slides
Webcast
Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial
Presenter: Do-Youn Oh
Session: Mini Oral session - Gastrointestinal tumours
Resources:
Slides
Webcast
Immunoscore predicts significant differences in time to recurrence in stage I colon cancer patients
Presenter: Jerome Galon
Session: Mini Oral session - Gastrointestinal tumours
Resources:
Slides
Webcast
A multicenter phase II study of neoadjuvant FOLFOXIRI followed by concurrent capecitabine and radiotherapy for high risk rectal cancer: A final report
Presenter: Gigi Lam
Session: Mini Oral session - Gastrointestinal tumours
Resources:
Slides
Webcast